Urinary Tract Infection Treatment Market
Urinary Tract Infection Treatment Market Analysis by Drug Class (Penicillin and Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides), by Indication (Complicated UTI, Uncomplicated UTI), by Distribution Channel & Regional Forecast 2021-2031
Analysis of Urinary Tract Infection Treatment market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Urinary Tract Infection Treatment Market Outlook (2021-2031)
The global urinary tract infection treatment market was valued at US$ 10.5 Bn in 2021, and is expected to increase at a CAGR of 2.1% to reach US$ 12.9 Bn by 2031.
|
Data Points |
Market Insights |
|
Urinary Tract Infection Treatment Market Size (2020) |
US$ 10.3 Bn |
|
Forecasted Market Value (2031) |
US$ 12.9 Bn |
|
Global Market Growth Rate (2021-2031) |
2.1% |
|
Share of Top 5 Countries |
50.8% |
Urinary Tract Infection Treatment Demand Analysis (2016-2020) Compared to Market Forecasts (2021-2031)
As per industry analysis by Fact.MR, a market research and competitive intelligence provider, sales of urinary tract infection treatment solutions and devices increased at a CAGR of 1.5% from 2016 to 2020.
Most pharmaceutical companies are developing antibiotics with more than one API to combat multi-drug resistant bacteria and broaden the activity spectrum of drugs. Many companies are also focusing on new drug development for uncontrolled UTI infection. Combination of products is accepted widely among physicians across the globe, and is expected to boost UTI treatment market growth over the forecast period.
Furthermore, FDA approval for new dosage forms of existing drugs is another factor that is expected to fuel development of the urinary tract infection therapeutics market over the forecast period. Also, herbal medicines for UTI treatment are gaining popularity across regions.
- In November 2020, Allergan announced FDA acceptance of Supplemental New Drug Indication for Avycaz for the treatment of patients with complicated Urinary Tract Infections (cUTI) and complicated Intra-abdominal Infections (cIAI).
Fact.MR projects the global urinary tract infection treatment market to expand at a moderate CAGR of 2.1% through 2031.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Does the Future of UTI Infection Medicine Manufacturers Look Like?
Rising prevalence of urinary tract infections such as bladder infection, kidney infection or urethra infection, etc., and rising cases of uncomplicated urinary tract infection, are expected to boost demand for Urinary Tract Infection (UTI) treatment. Unhealthy lifestyles and high consumption of alcohol trigger chronic kidney diseases such as renal failure and bladder cancer, and this is driving kidney infection treatment demand.
Also, physicians’ preference for antibiotics for any kind of urinary tract infection is driving the antibiotics market. Collaboration of major players with research institutes are complimenting market growth by giving more treatment options for UTI treatment.
Beside antibiotics as the first line treatment for urinary tract infection, patients are looking for surgery and stimulation therapy for fast recovery. This creates demand for alternative therapies for UTI, which include a set of healthcare and medical systems and practices and products that are usually not considered to be the part of mainstream medicines, such as taking natural and herbal medicines for UTI.
Rising hospitalization rates for UTI, increasing geriatric population, and growing drug resistance are driving the interstitial cystitis market, which basically includes treatment for the chronic conditions called interstitial cystitis, and causes pain due to bladder pressure, and sometimes pelvic pain.
Driven by this, the global UTI infection medicine market is expected to rise at 2.1% CAGR through 2031.
Which Factors are Restraining Demand for Urinary Tract Infection Treatment?
Adverse effects of antibiotics are expected to hamper the urinary tract infection therapeutics market growth in the years ahead. UTI is treated with a vast range of antibiotics. However, these antibiotics have one or more adverse effects such as tendon problems, muscle weakness, allergic reactions, central nervous system-related problems, etc.
These problems can be more serious in the geriatric population, pregnant women, and children where the prevalence of UTI is higher. Additionally, continuous mutation of bacteria for existing drugs also declines market growth for UTI infection medicines to some extent for urinary tract infection treatment.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
Why is the U.S. a Leading Market for Urinary Tract Infection Treatment?
“Developed Medical Infra Driving UTI Infection Medication Sales”
The U.S. accounted for 91.4% of the North America urinary tract infection treatment market in 2021, owing to the development of many treatment facilities and rising investments in the healthcare sector. Moreover, increased rate of approvals by the U.S FDA has led to higher product penetration, making the U.S a high revenue generating country for medicines for UTI pain.
- For instance, in January 2020, Merck announced U.S. FDA approval of its drug DIFICID (fidaxomicin), which is used for the treatment of Clostridioides difficile bacteria in the pediatric population and older children.
Also, a good reimbursement scenario and rise in awareness regarding UTIs will offer lucrative opportunities for UTI treatment providers in the country.
Which Country is Leading Market UTI Market Growth in Europe?
“Germany Leading Bladder Infection Medication Demand Growth”
Germany accounted for 22.6% market share in the Europe medicines for UTI pain and treatment in 2021. Factors such as increase in geriatric population, presence of research & development programs, and high-class healthcare infrastructure are boosting demand in the urinary cystitis management market in Germany.
What’s Compelling UTI Market Players to Focus on China?
“UTI Pain Relief Medication Highly Sought-after in the Country”
China accounted for 68.9% of the East Asia market for bladder infection medications in 2021, owing to factors such as major manufacturing expansion in the country and high production capacity for antibiotic drugs.
High outsourcing potential and cost-effective production capacity for antibiotics are generating high revenue share for urinary tract infection treatment providers in China.
Category-wise Insights
Which Drug Class is Lending Traction to Market Expansion?
“Demand High for Quinolones as a Bladder Infection Medication”
By drug class, quinolones held a high share of 45.7% in 2021. Quinolones are broadly active against most Gram-negative and Gram-positive organisms, so that multi-drug resistance is avoided in the treatment of urinary tract infection.
These drugs have the capability to improve quality of life and combat symptoms with high therapeutic effect. These lifesaving advantages of quinolones make them the most lucrative and highly adopted products across regions.
Why Complicated UTI Will Give Market Players Great Growth Potential?
“cUTI Treatment to Substantially Contribute to Market Expansion”
Demand for complicated UTI treatment is expected to rise at 2.7% CAGR over the forecast period. Urinary tract infection is one of the most common infectious disease caused by bacteria. Complicated urinary tract infection can affect anyone, irrespective of gender or age group, and is mostly related to either structural or functional abnormalities in the urinary tract.
Development of multidrug-resistance bacteria is more common in cUTI, and there has been an increase in the number of multidrug-resistance bacteria, due to which, cUTI cases are increasing across the globe.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Impact of COVID-19 Crisis
COVID-19 has had a moderately positive impact on this market due to increase in urinary tract infections in patient post COVID-19 recovery. Moreover, urinary tract infection leads to severe abdominal pain, and hence, treatment becomes mandatory.
Competitive Landscape
Companies such as Pfizer and GSK, operating in the urinary tract infection treatment market, are actively entering into partnerships and collaborations, and sometimes even divestiture of some of their business divisions to maintain a relative position in the market.
- Pfizer Inc. announced the completion of a transaction to spin off its Upjohn business and combine it with Mylan N.V. to form Viatris Inc in November 2020.
- In January 2019, GSK announced that it completed the acquisition of Tesaro for approximately US$ 5.1 Bn.
Urinary Tract Infection Treatment Report Scope
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Billion for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Urinary Tract Infection Treatment Industry Survey by Category
-
By Drug Class:
- Penicillin and Combinations
- Amoxicillin
- Amoxicillin and Clavulanate
- Potassium
- Others
- Quinolones
- Ciprofloxaxin
- Levofloxaxin
- Nalidixic acid
- Norfloxacin
- Others
- Cephalosporin
- Ceftriaxone
- Cefuroxime
- Cefixime
- Cephalexin
- Aminoglycoside Antibiotics
- Amikacin
- Gentamicin
- Sulphonamides (Sulfamethoxazole +Trimethoprim)
- Azoles and Amphotericin B
- Tetracycline (Doxycycline)
- Nirtofurans (Nitrofurantoin)
- Other
- Penicillin and Combinations
-
By Indication:
- Complicated UTI
- Uncomplicated UTI
-
By Distribution Channel:
- Hospital Pharmacies
- Gynecology and Urology Clinics
- Drug Stores
- Retail Pharmacies
- Online Drug Stores
-
By Region:
- North America Urinary Tract Infection Treatment Market
- Latin America Urinary Tract Infection Treatment Market
- Europe Urinary Tract Infection Treatment Market
- East Asia Urinary Tract Infection Treatment Market
- South Asia Urinary Tract Infection Treatment Market
- Oceania Urinary Tract Infection Treatment Market
- Middle East and Africa (MEA) Urinary Tract Infection Treatment Market
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Market Overview 1.3. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Key Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 4. Key Success Factors 4.1. Treatment Regimens For Antimicrobial Therapy In Uncomplicated Cystitis 4.2. Urinary Tract Infection Antibiotic Treatment Cycle 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Favourable Incentive & Reimbursement Policies 5.1.2. Increasing Consumption of Antibiotics per Capita 5.2. Forecast Factors - Relevance & Impact 5.2.1. Manufacturers Creating Value through Innovation 5.2.2. Increasing prevalence of UTIs 5.2.3. High Adoption Rate 5.2.4. Regulatory scenario 5.2.5. Changing competitive landscape for antibiotics. 5.2.6. Increase in Drug Resistance 5.2.7. Patent Loss of Branded Drugs 5.3. Value Chain 5.4. Market Dynamics 5.4.1. Drivers 5.4.2. Restraints 5.4.3. Opportunity Analysis 6. COVID19 Crisis Impact Analysis 6.1. Current COVID-19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as compared to 2008 financial analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Drug Class 6.4.2. Revenue By Indication 6.4.3. Revenue By Distribution Channel 6.4.4. Revenue By Country 6.5. 2021 Market Scenario 6.6. Recovery Scenario - Short term, Midterm and Long Term Impact 7. Global Urinary Tract Infection Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020 7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031, by Drug Class 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2016-2020 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2021-2031 8.3.1. Penicillin and Combinations 8.3.1.1. Amoxicillin 8.3.1.2. Amoxicillin + Clavulanate Potassium 8.3.1.3. Others 8.3.2. Diagnostic catheters 8.3.2.1. Ciprofloxaxin 8.3.2.2. Levofloxacin 8.3.2.3. Nalidixic acid 8.3.2.4. Norfloxacin 8.3.2.5. Others 8.3.3. Cephalosporin 8.3.3.1. Ceftriaxone 8.3.3.2. Cefuroxime 8.3.3.3. Cefixime 8.3.3.4. Cephalexin 8.3.4. Aminoglycoside Antibiotics 8.3.4.1. Amikacin 8.3.4.2. Gentamicin 8.3.5. Sulphonamides (Sulfamethoxazole + Trimethoprim) 8.3.6. Azoles and Amphotericin B 8.3.7. Tetracycline (Doxycycline) 8.3.8. Nirtofurans (Nitrofurantoin) 8.3.9. Others 8.4. Market Attractiveness Analysis By Drug Class 9. Global Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031, by Indication 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2016-2020 9.3. Current and Future Market Size (US$ Mn Analysis and Forecast By Indication, 2021-2031 9.3.1. Complicated UTIs 9.3.2. Uncomplicated UTIs 9.4. Market Attractiveness Analysis By Indication 10. Global Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031, by Distribution Channel 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021-2031 10.3.1. Hospitals Pharmacies 10.3.2. Gynaecology and Urology Clinics 10.3.3. Drug store 10.3.4. Retail Pharmacies 10.3.5. Online drug stores 10.4. Market Attractiveness Analysis By Distribution Channel 11. Global Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. South Asia 11.3.5. East Asia 11.3.6. Oceania 11.3.7. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Distribution Channel 12. North America Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020 12.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Drug Class 12.3.3. By Indication 12.3.4. By Distribution Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Drug Class 12.4.3. By Indication 12.4.4. By Distribution Channel 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 13. Latin America Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020 13.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Rest of Latin America 13.3.2. By Drug Class 13.3.3. By Indication 13.3.4. By Distribution Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Drug Class 13.4.3. By Indication 13.4.4. By Distribution Channel 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Europe Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020 14.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. U.K. 14.3.1.5. Spain 14.3.1.6. BENELUX 14.3.1.7. Russia 14.3.1.8. Rest of Europe 14.3.2. By Drug Class 14.3.3. By Indication 14.3.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Drug Class 14.4.3. By Indication 14.4.4. By Distribution Channel 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. South Asia Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020 15.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Drug Class 15.3.3. By Indication 15.3.4. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Drug Class 15.4.3. By Indication 15.4.4. By Distribution Channel 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. East Asia Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020 16.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Drug Class 16.3.3. By Indication 16.3.4. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Drug Class 16.4.3. By Indication 16.4.4. By Distribution Channel 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. Oceania Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020 17.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Drug Class 17.3.3. By Indication 17.3.4. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Drug Class 17.4.3. By Indication 17.4.4. By Distribution Channel 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020 18.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Turkey 18.3.1.3. South Africa 18.3.1.4. Northern Africa 18.3.1.5. Rest of Middle East and Africa 18.3.2. By Drug Class 18.3.3. By Indication 18.3.4. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Drug Class 18.4.3. By Indication 18.4.4. By Distribution Channel 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Key and Emerging Countries Urinary Tract Infection Treatment Market Analysis 2016-2020 and Forecast 2021-2031 19.1. Introduction 19.1.1. Market Value Proportion Analysis, By Key Countries 19.1.2. Global Vs. Country Growth Comparison 19.2. U.S. Urinary Tract Infection Treatment Market Analysis 19.2.1. By Drug Class 19.2.2. By Indication 19.2.3. By Distribution Channel 19.3. Canada Urinary Tract Infection Treatment Market Analysis 19.3.1. By Drug Class 19.3.2. By Indication 19.3.3. By Distribution Channel 19.4. Mexico Urinary Tract Infection Treatment Market Analysis 19.4.1. By Drug Class 19.4.2. By Indication 19.4.3. By Distribution Channel 19.5. Brazil Urinary Tract Infection Treatment Market Analysis 19.5.1. By Drug Class 19.5.2. By Indication 19.5.3. By Distribution Channel 19.6. U.K. Urinary Tract Infection Treatment Market Analysis 19.6.1. By Drug Class 19.6.2. By Indication 19.6.3. By Distribution Channel 19.7. Germany Urinary Tract Infection Treatment Market Analysis 19.7.1. By Drug Class 19.7.2. By Indication 19.7.3. By Distribution Channel 19.8. France Urinary Tract Infection Treatment Market Analysis 19.8.1. By Drug Class 19.8.2. By Indication 19.8.3. By Distribution Channel 19.9. Italy Urinary Tract Infection Treatment Market Analysis 19.9.1. By Drug Class 19.9.2. By Indication 19.9.3. By Distribution Channel 19.10. Spain Urinary Tract Infection Treatment Market Analysis 19.10.1. By Drug Class 19.10.2. By Indication 19.10.3. By Distribution Channel 19.11. BENELUX Urinary Tract Infection Treatment Market Analysis 19.11.1. By Drug Class 19.11.2. By Indication 19.11.3. By Distribution Channel 19.12. Russia Urinary Tract Infection Treatment Market Analysis 19.12.1. By Drug Class 19.12.2. By Indication 19.12.3. By Distribution Channel 19.13. China Urinary Tract Infection Treatment Market Analysis 19.13.1. By Drug Class 19.13.2. By Indication 19.13.3. By Distribution Channel 19.14. Japan Urinary Tract Infection Treatment Market Analysis 19.14.1. By Drug Class 19.14.2. By Indication 19.14.3. By Distribution Channel 19.15. South Korea Urinary Tract Infection Treatment Market Analysis 19.15.1. By Drug Class 19.15.2. By Indication 19.15.3. By Distribution Channel 19.16. India Urinary Tract Infection Treatment Market Analysis 19.16.1. By Drug Class 19.16.2. By Indication 19.16.3. By Distribution Channel 19.17. Thailand Urinary Tract Infection Treatment Market Analysis 19.17.1. By Drug Class 19.17.2. By Indication 19.17.3. By Distribution Channel 19.18. Malaysia Urinary Tract Infection Treatment Market Analysis 19.18.1. By Drug Class 19.18.2. By Indication 19.18.3. By Distribution Channel 19.19. Indonesia Urinary Tract Infection Treatment Market Analysis 19.19.1. By Drug Class 19.19.2. By Indication 19.19.3. By Distribution Channel 19.20. Australia Urinary Tract Infection Treatment Market Analysis 19.20.1. By Drug Class 19.20.2. By Indication 19.20.3. By Distribution Channel 19.21. New Zealand Urinary Tract Infection Treatment Market Analysis 19.21.1. By Drug Class 19.21.2. By Indication 19.21.3. By Distribution Channel 19.22. GCC Countries Urinary Tract Infection Treatment Market Analysis 19.22.1. By Drug Class 19.22.2. By Indication 19.22.3. By Distribution Channel 19.23. Turkey Urinary Tract Infection Treatment Market Analysis 19.23.1. By Drug Class 19.23.2. By Indication 19.23.3. By Distribution Channel 19.24. South Africa Urinary Tract Infection Treatment Market Analysis 19.24.1. By Drug Class 19.24.2. By Indication 19.24.3. By Distribution Channel 19.25. Northern Africa Urinary Tract Infection Treatment Market Analysis 19.25.1. By Drug Class 19.25.2. By Indication 19.25.3. By Distribution Channel 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Merck & Co., Inc. 20.3.1.1. Overview 20.3.1.2. Device Portfolio 20.3.1.3. Profitability by Market Segments (Device/Channel/Region) 20.3.1.4. Sales Footprint 20.3.1.5. Strategy Overview 20.3.1.5.1. Marketing Strategy 20.3.1.5.2. Device Strategy 20.3.1.5.3. Channel Strategy 20.3.2. Bayer AG 20.3.2.1. Overview 20.3.2.2. Device Portfolio 20.3.2.3. Profitability by Market Segments (Device/Channel/Region) 20.3.2.4. Sales Footprint 20.3.2.5. Strategy Overview 20.3.2.5.1. Marketing Strategy 20.3.2.5.2. Device Strategy 20.3.2.5.3. Channel Strategy 20.3.3. GlaxoSmithKline Pharmaceuticals Ltd. 20.3.3.1. Overview 20.3.3.2. Device Portfolio 20.3.3.3. Profitability by Market Segments (Device/Channel/Region) 20.3.3.4. Sales Footprint 20.3.3.5. Strategy Overview 20.3.3.5.1. Marketing Strategy 20.3.3.5.2. Device Strategy 20.3.3.5.3. Channel Strategy 20.3.4. Pfizer 20.3.4.1. Overview 20.3.4.2. Device Portfolio 20.3.4.3. Profitability by Market Segments (Device/Channel/Region) 20.3.4.4. Sales Footprint 20.3.4.5. Strategy Overview 20.3.4.5.1. Marketing Strategy 20.3.4.5.2. Device Strategy 20.3.4.5.3. Channel Strategy 20.3.5. Allergan Plc 20.3.5.1. Overview 20.3.5.2. Device Portfolio 20.3.5.3. Profitability by Market Segments (Device/Channel/Region) 20.3.5.4. Sales Footprint 20.3.5.5. Strategy Overview 20.3.5.5.1. Marketing Strategy 20.3.5.5.2. Device Strategy 20.3.5.5.3. Channel Strategy 20.3.6. Almirall SA 20.3.6.1. Overview 20.3.6.2. Device Portfolio 20.3.6.3. Profitability by Market Segments (Device/Channel/Region) 20.3.6.4. Sales Footprint 20.3.6.5. Strategy Overview 20.3.6.5.1. Marketing Strategy 20.3.6.5.2. Device Strategy 20.3.6.5.3. Channel Strategy 20.3.7. Bristol-Myers Squibb 20.3.7.1. Overview 20.3.7.2. Device Portfolio 20.3.7.3. Profitability by Market Segments (Device/Channel/Region) 20.3.7.4. Sales Footprint 20.3.7.5. Strategy Overview 20.3.7.5.1. Marketing Strategy 20.3.7.5.2. Device Strategy 20.3.7.5.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01A: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 01B: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 02: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 03: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 04: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 05: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 06A: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 06B: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 07: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 08: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 09: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 11: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 12: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 13: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 14A: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 14B: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 15: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 16: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 17: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 19: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 20: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 21A: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 21B: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 22: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 23: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 24: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 25A: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 25B: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 26: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 27: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 28: MEA Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
Table 29A: MEA Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 29B: MEA Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class
Table 30: MEA Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication
Table 31: MEA Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2016–2020
Figure 02: Global Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 03: Global Urinary Tract Infection Treatment Market Absolute $ Opportunity, 2021–2031
Figure 04: Global Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 05: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Drug Class, 2021 – 2031
Figure 06: Global Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 07: Global Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 08: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Indication, 2021 – 2031
Figure 09: Global Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 10: Global Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2021 & 2031
Figure 11: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2021 – 2031
Figure 12: Global Urinary Tract Infection Treatment Market Analysis by Distribution Channel –2021 & 2031
Figure 13: Global Urinary Tract Infection Treatment Market Analysis by Region–2021 & 2031
Figure 14: Global Urinary Tract Infection Treatment Market Y-o-Y Growth Projections by Region, 2021 – 2031
Figure 15: Global Urinary Tract Infection Treatment Market Analysis by Region–2021 & 2031
Figure 16: North America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2016–2020
Figure 17: North America Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 18: North America Urinary Tract Infection Treatment Market Analysis by Country–2021 & 2031
Figure 19: North America Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 20: North America Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 21: North America Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2021 & 2031
Figure 22: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2016–2020
Figure 23: Latin America Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 24: Latin America Urinary Tract Infection Treatment Market Analysis by Country–2021 & 2031
Figure 25: Latin America Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 26: Latin America Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 27: Latin America Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2021 & 2031
Figure 28: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2016–2020
Figure 29: Europe Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 30: Europe Urinary Tract Infection Treatment Market Analysis by Country–2021 & 2031
Figure 31: Europe Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 32: Europe Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 33: Europe Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2021 & 2031
Figure 34: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2016–2020
Figure 35: South Asia Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 36: South Asia Urinary Tract Infection Treatment Market Analysis by Country–2021 & 2031
Figure 37: South Asia Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 38: South Asia Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 39: South Asia Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2021 & 2031
Figure 40: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2016–2020
Figure 41: East Asia Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 42: East Asia Urinary Tract Infection Treatment Market Analysis by Country–2021 & 2031
Figure 43: East Asia Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 44: East Asia Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 45: East Asia Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2021 & 2031
Figure 46: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2016–2020
Figure 47: Oceania Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 48: Oceania Urinary Tract Infection Treatment Market Analysis by Country–2021 & 2031
Figure 49: Oceania Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 50: Oceania Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 51: Oceania Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2021 & 2031
Figure 52: MEA Urinary Tract Infection Treatment Market Size (US$ Mn) Analysis, 2016–2020
Figure 53: MEA Urinary Tract Infection Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 54: MEA Urinary Tract Infection Treatment Market Analysis by Country–2021 & 2031
Figure 55: MEA Urinary Tract Infection Treatment Market Analysis by Drug Class–2021 & 2031
Figure 56: MEA Urinary Tract Infection Treatment Market Analysis by Indication–2021 & 2031
Figure 57: MEA Urinary Tract Infection Treatment Market Analysis by Distribution Channel–2021 & 2031
Figure 58: U.S. Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 59: Global Vs. U.S. Growth Comparison
Figure 60: U.S. Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 61: U.S. Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 62: U.S. Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 63: Canada Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 64: Global Vs. Canada Growth Comparison
Figure 65: Canada Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 66: Canada Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 67: Canada Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 68: Brazil Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 69: Global Vs. Brazil Growth Comparison
Figure 70: Brazil Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 71: Brazil Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 72: Brazil Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 73: Mexico Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 74: Global Vs. Mexico Growth Comparison
Figure 75: Mexico Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 76: Mexico Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 77: Mexico Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 78: Germany Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 79: Global Vs. Germany Growth Comparison
Figure 80: Germany Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 81: Germany Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 82: Germany Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 83: Italy Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 84: Global Vs. Italy Growth Comparison
Figure 85: Italy Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 86: Italy Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 87: Italy Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 88: France Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 89: Global Vs. France Growth Comparison
Figure 90: France Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 91: France Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 92: France Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 93: U.K Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 94: Global Vs. U.K Growth Comparison
Figure 95: U.K Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 96: U.K Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 97: U.K Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 98: Spain Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 99: Global Vs. Spain Growth Comparison
Figure 100: Spain Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 101: Spain Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 102: Spain Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 103: BENULUX Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 104: Global Vs. BENULUX Growth Comparison
Figure 105: BENULUX Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 106: BENULUX Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 107: BENULUX Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 108: Russia Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 109: Global Vs. Russia Growth Comparison
Figure 110: Russia Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 111: Russia Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 112: Russia Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 113: India Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 114: Global Vs. India Growth Comparison
Figure 115: India Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 116: India Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 117: India Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 118: Thailand Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 119: Global Vs. Thailand Growth Comparison
Figure 120: Thailand Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 121: Thailand Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 122: Thailand Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 123: Malaysia Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 124: Global Vs. Malaysia Growth Comparison
Figure 125: Malaysia Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 126: Malaysia Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 127: Malaysia Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 128: Indonesia Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 129: Global Vs. Indonesia Growth Comparison
Figure 130: Indonesia Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 131: Indonesia Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 132: Indonesia Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 133: China Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 134: Global Vs. China Growth Comparison
Figure 135: China Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 136: China Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 137: China Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 138: Japan Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 139: Global Vs. Japan Growth Comparison
Figure 140: Japan Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 141: Japan Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 142: Japan Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 143: South Korea Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 144: Global Vs. South Korea Growth Comparison
Figure 145: South Korea Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 146: South Korea Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 147: South Korea Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 148: Australia Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 149: Global Vs. Australia Growth Comparison
Figure 150: Australia Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 151: Australia Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 152: Australia Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 153: New Zealand Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 154: Global Vs. New Zealand Growth Comparison
Figure 155: New Zealand Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 156: New Zealand Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 157: New Zealand Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 158: GCC Countries Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 159: Global Vs. GCC Countries Growth Comparison
Figure 160: GCC Countries Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 161: GCC Countries Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 162: GCC Countries Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 163: Turkey Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 164: Global Vs. Turkey Growth Comparison
Figure 165: Turkey Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 166: Turkey Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 167: Turkey Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 168: Northern Africa Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 169: Global Vs. Northern Africa Growth Comparison
Figure 170: Northern Africa Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 171: Northern Africa Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 172: Northern Africa Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Figure 173: South Africa Urinary Tract Infection Treatment Market Value Proportion Analysis (2020)
Figure 174: Global Vs. South Africa Growth Comparison
Figure 175: South Africa Urinary Tract Infection Treatment Market Share Analysis (%), by Product
Figure 176: South Africa Urinary Tract Infection Treatment Market Share Analysis (%), by Indication
Figure 177: South Africa Urinary Tract Infection Treatment Market Share Analysis (%), by Distribution Channel
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the urinary tract infection treatment market currently worth?
The global urinary tract infection treatment market was worth US$ 10.3 Bn in.
What is be demand outlook for urinary tract infection treatment?
The market is expected to reach US$ 12.9 Bn by the end of 2031, expanding at a CAGR of 2.1%.
At what CAGR did the UTI market grow over the past 5 years?
The market for urinary tract infection treatment progressed at 1.5% CAGR from 2016 to 2020.
What are the key trends related to urinary tract infection treatment?
Highly saturated market, increasing per capita consumption of antibiotics, rise in complicated UTI (cUTI) cases, and acquisitions & regional expansion are key trends in this space.
Which are the top 5 countries driving demand for urinary tract infection treatment?
The U.S., Japan, China, India, and France are the top 5 countries driving demand for UTI treatment.
What is the outlook for the North America UTI market?
North America is a key market for urinary tract infection treatment, with the U.S. expected to account for 91.4% market share.
At what percentage is demand for urinary tract infection treatment expected to register growth in Europe?
Europe UTI market growth is projected at 2.2% CAGR through 2031.
Who are the leading urinary tract infection treatment providers?
Leading market players are Bayer AG, GlaxoSmithKline Pharmaceuticals Ltd., Pfizer, Allergan Plc, Almirall SA, Bristol-Myers Squibb, and Merck & Co., Inc.
What are the key market statistics for UTI treatment in South Korea and Japan?
The South Korea market is expected to exhibit 1.7% CAGR, while Japan is set to experience 2% CAGR, over the decade.
Urinary Tract Infection Treatment Market